Highlights Eli Lilly and Company Lima

Equities

End-of-day quote Lima Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
903.6 ^USD	0.00%		0.00%	0.00%

Jul. 16	Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	MT
Jul. 16	Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793	MT

Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	Jul. 16	MT
Novo owner backs Swiss biotech Asceneuron in $100 million round	Jul. 16	RE
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market	Jul. 12	RE
Ozempic linked with lower dementia risk, nicotine use, British study finds	Jul. 12	RE
EU Drug Regulator Issues New Safety Measures for GLP-1 Drugs Amid Aspiration Risk Concerns	Jul. 12	MT
Health Care Up as Obesity-Drug Wars Continue -- Health Care Roundup	Jul. 11	DJ
Pfizer moves forward with once-daily weight loss drug	Jul. 11	RE
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10
Analysis Shows Use of Novo Nordisk's Wegovy, Ozempic for Weight Loss Declines After Two Years	Jul. 10	MT
Sellers of fake Ozempic to face charges in Austrian court	Jul. 09	RE
Mixed feelings	Jul. 09
Eli Lilly's Mounjaro Provides Better Weight Loss Compared to Semaglutide-Based Drugs, Study Shows	Jul. 09	MT
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss	Jul. 09	RE
Health Care Flat Amid Deal Activity -- Health Care Roundup	Jul. 08	DJ
S&P 500, Nasdaq Extend Record Closing Runs	Jul. 08	MT
S&P 500, Nasdaq Extend Record High Closing Runs	Jul. 08	MT
US Equities Markets End Mixed as Investors Await Inflation Data	Jul. 08	MT
Sector Update: Health Care Stocks Softer Late Afternoon	Jul. 08	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	Jul. 08	MT
Sector Update: Health Care	Jul. 08	MT

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT